Levothyroxine Sodium
- Product NDC
- 63323-647
- 11-digit product format
- 633230647
- Labeler code
- 63323
- Product ID
- 63323-647_1da8e5bc-aeb7-4168-a8c3-e1d9a9d167ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LEVOTHYROXINE SODIUM ANHYDROUS
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA202231
- Marketing category
- NDA
- Marketing start
- 2011-06-24
- Substance
- LEVOTHYROXINE SODIUM ANHYDROUS
- Active strength
- 200 ug/5mL
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 054I36CPMN | LEVOTHYROXINE SODIUM ANHYDROUS | 55-03-8 | LEVOTHYROXINE SODIUM ANHYDROUS |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 63323-647-10 | 63323064710 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-647-10) / 5 mL in 1 VIAL, SINGLE-DOSE | 2011-06-24 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2025-04-17 | HUMAN PRESCRIPTION DRUG LABEL | 7 |